Electrostatic potential on human leukocyte antigen: Implications for putative mechanism of chronic beryllium disease

Environmental Health Perspectives

Volumn 111, Issue 15, 2003, Pages 1827-1834

  Snyder, James A ^a   Weston, Ainsley ^a,b   Tinkle, Sally S ^a   Demchuk, Eugene ^a,b  

^a NATIONAL INSTITUTE FOR OCCUPATIONAL SAFETY AND HEALTH   (United States)

^b WEST VIRGINIA UNIVERSITY   (United States)

Author keywords

Chronic beryllium disease; Gene environment interactions; Genetic marker; Genetic susceptibility; HLA DP; Human leukocyte antigen; Lung; Sensitization

Indexed keywords

BERYLLIUM; CATION; COBALT; HLA ANTIGEN; HLA DP ANTIGEN; HLA DR ANTIGEN; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 2;

ALLOTYPE; AMINO ACID SUBSTITUTION; ANTIGEN BINDING; ANTIGEN RECOGNITION; ANTIGEN SPECIFICITY; ARTICLE; BERYLLIOSIS; BINDING SITE; CALCULATION; CHRONIC DISEASE; CONTROLLED STUDY; ELECTRICITY; GENE LOCUS; GENETIC SUSCEPTIBILITY; HUMAN; LUNG DISEASE; OCCUPATIONAL EXPOSURE; PRIORITY JOURNAL; PROTEIN DOMAIN; PROTEIN STRUCTURE; SEQUENCE ALIGNMENT; X RAY ANALYSIS;

EID: 0347504481     PISSN: 00916765     EISSN: None     Source Type: Journal    
DOI: 10.1289/ehp.6327     Document Type: Article

References (31)

1. Amicosante M, Saharico N, Berretta F, Arroyo J, Lombardi G, Lechler R, at al. 2001. Beryllium binding to HLA-DP molecule carrying the marker of susceptibility to berylliosis glutamate β69. Hum Immunol 43:686-693.
2. Budinger L, Hertl M. 2000. Immunologic mechanisms in hypersensitivity reactions to metal ions: an overview. Allergy 55:108-115.
3. Cunningham-Rundles S, Giardina PJ, Grady RW Califano C, McKenzie P, de Sousa M. 2000. Effect of transfusional iron overload on immune response. J Infect Dis 182:S115-S121.
4. Díaz G, Catálfamo M, Coiras MT, Álvarez AM, Jaraquemada D, Nombela C, et aL 1998. HLA-DPβ residue 69 plays a crucial role in allorecognition. Tissue Antigens 52:27-36.
5. EBI 2003. IMGT/HLA Database. Hinxton, UK: European Molecular Biology Laboratory - European Bioinformatics Institute. Available: http://www.ebi.ac.uk/imgt/hla/allele [accessed 4 March 2003].
6. + T cells underlies disease-susceptibility HLA-DP alleles in chronic beryllium disease. Proc Natl Acad Sci USA 97:12717-12722.
7. Kolanz ME. 2001. Introduction to beryllium uses, regulatory history, and disease. Appl Occup Environ Hyg 16:559-567.
8. Kreiss K, Mroz MM, Zhen B, Wiedemann H, Barna B. 1997. Risks of beryllium disease related to work processes at a metal, alloy, and oxide production plant. Occup Environ Med 54:605-612.
9. Lawrence DA, McCabe MJ Jr. 2002. Immunomodulation by metals. Int Immunopharmacol 2:293-302.
10. Li YL, Li HM, Martin R, Mariuzza RA. 2000. Structural basis for the binding of an immunodominant peptide from myelin basic protein in different registers by two HLA-DR2 proteins. J Mol Biol 304:177-188.
11. Lombardi G, Germain C, Uren J, Fiorillo MT, du Bois RM, Jones-Williams W, et al. 2001. HLA-DP allele-specific T cell responses to beryllium account for DP-associated susceptibility to chronic beryllium disease. J Immunol 166:3549-3555.
12. Maier LA. 2001. Beryllium health effects in the era of the beryllium lymphocyte proliferation test. Appl Occup Environ Hyg 16:514-520.
13. Marsh SGE. 2003. Nomenclature for factors of the HLA system, update March 2003. Eur J Immunogenet 30:239,
14. McCanlies E, Kreiss K, Weston A. 2003. HLA-DPB1 and chronic beryllium disease: a HuGE review. Am J Epidemiol 157:386-398.
15. OSHA. 2002. Preventing Adverse Effects from Exposure to Beryllium in Dental Laboratories. HIB 02-04-19 (rev. 05-14-02). Washington, DC:U.S. Department of Labor Occupational Safety and Health Administration.
16. Potolicchio 1, Festucci A, Hausler P, Sorrentino R. 1999. HLA-DP molecules bind cobalt: a possible explanation for the genetic association with hard metal disease. Eur J Immunol 29:2140-2147.
17. Powell MJD. 1977. Restart procedures for the conjugate gradient method. Math Progr 12:241-254.
18. Powers MB. 1991. History of beryllium. In: Beryllium: Biomedical and Environmental Aspects (Rossman MD, Preuss PO, Powers MB, eds). Baltimore, MD:Williams and Wilkins.
19. Richeldi L, Kreiss K, Mroz MM, Zhen BG, Tartoni P, Saltini C.1997. Interaction of genetic and exposure factors in the prevalence of berylliosis. Am J Ind Med 32:337-340.
20. Richeldi L, Sorrentino R, Saltini C. 1993. HLA-DPB1 glutamate 69: a genetic marker of beryllium disease. Science 262:242-244.
21. Rossman MD, Stubbs J, Lee CW, Argyris E, Magira E, Monos D. 2002. Human leukocyte antigen Class II amino acid epitopes: susceptibility and progression markers for beryllium hypersensitivity. Am J Respir Crit Care Med 165:788-794.
22. Saltini C, Richeldi L, Losi M, Amicosante M, Voorter C, van den Berg-Loonen E, et al. 2001. Major histocompatibility locus genetic markers of beryllium sensitization and disease. Eur Respir J 18:677-684.
23. Saltini C, Winestock K, Kirby M, Pinkston P, Crystal RG. 1989. Maintenance of alveolitis in patients with chronic beryllium disease by beryllium-specific helper T cells N Engl J Med 320:1103-1109.
24. Sanderson WT, Henneberger PK, Martyny J, Ellis K, Mroz MM, Newman LS. 1999. Beryllium corltamination inside vehicles of machine shop workers. Appl Occup Environ Hyg 14:223-230.
25. SAS Institute, Inc. 1999. User's Guide. Statistics, Version 7-1, Vol 4. Cary, NC:SAS Institute, Inc.
26. Sitkoff D. Sharp KA, Honig B. 1994. Accurate calculation of hydration free energies using macroscopic solvent models J Phys Chem 98:1978-1988.
27. Tinkle SS, Weston A, Flint MS. 2003. Genetic factors modify the risk of developing beryllium disease. Semin Respir Crit Care Med 24:169-177.
28. Vriend G. 1990. WHATIF: a molecular modeling and drug design program. J Mol Graph 8:52-56.
29. Wang Z, Farris GM, Newman LS, Shou Y, Maier LA, Smith HN, et al. 2001. Beryllium sensitivity is linked to HLA-DP genotype. Toxicology 165:27-38.
30. Wang Z, White PS, Petrovic M, Tatum OL, Newman LS, Maier LA, et al, 1999. Differential susceptibilities to chronic beryllium disease contributed by different Glu69 HLA-DPB1 and -DPA1 alleles. J Immunol 163:1647-1653.
31. Weiner SJ, Kollman PA, Case DA, Singh UC, Ghio C, Alagona S, et al. 1984. A new force-field for molecular mechanical simulation of nucleic-acids and proteins. J Am Chem Soc 106:765-784.